Filing Details
- Accession Number:
- 0001239241-15-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-19 20:58:32
- Reporting Period:
- 2015-06-17
- Filing Date:
- 2015-06-19
- Accepted Time:
- 2015-06-19 20:58:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1594864 | Juno Therapeutics Inc. | JUNO | Biological Products, (No Disgnostic Substances) (2836) | 463656275 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1239241 | B Anthony Evnin | C/O Venrock 3340 Hillview Avenue Palo Alto CA 94304 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-06-17 | 90,141 | $51.59 | 1,659,858 | No | 4 | S | Indirect | By Funds |
Common Stock | Disposition | 2015-06-17 | 94,080 | $52.65 | 1,565,778 | No | 4 | S | Indirect | By Funds |
Common Stock | Disposition | 2015-06-17 | 63,574 | $53.84 | 1,502,204 | No | 4 | S | Indirect | By Funds |
Common Stock | Disposition | 2015-06-17 | 28,603 | $54.70 | 1,473,601 | No | 4 | S | Indirect | By Funds |
Common Stock | Disposition | 2015-06-17 | 11,602 | $55.85 | 1,461,999 | No | 4 | S | Indirect | By Funds |
Common Stock | Disposition | 2015-06-17 | 12,000 | $56.32 | 1,449,999 | No | 4 | S | Indirect | By Funds |
Common Stock | Disposition | 2015-06-18 | 78,569 | $52.07 | 1,371,430 | No | 4 | S | Indirect | By Funds |
Common Stock | Disposition | 2015-06-18 | 154,495 | $52.74 | 1,216,935 | No | 4 | S | Indirect | By Funds |
Common Stock | Disposition | 2015-06-18 | 50,269 | $53.58 | 1,166,666 | No | 4 | S | Indirect | By Funds |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Funds |
No | 4 | S | Indirect | By Funds |
No | 4 | S | Indirect | By Funds |
No | 4 | S | Indirect | By Funds |
No | 4 | S | Indirect | By Funds |
No | 4 | S | Indirect | By Funds |
No | 4 | S | Indirect | By Funds |
No | 4 | S | Indirect | By Funds |
No | 4 | S | Indirect | By Funds |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 75,000 | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Venrock Healthcare Capital Partners, L.P. ("VHCP") and VHCP Co-Investment Holdings, LLC ("VHCP Co-Invest") on May 18, 2015.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.07 to $52.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) - (19) to this Form 4.
- Consists of 1,403,176 shares held by VHCP and 256,682 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.12 to $53.10, inclusive.
- Consists of 1,323,641 shares held by VHCP and 242,137 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.13 to $54.12, inclusive.
- Consists of 1,269,896 shares held by VHCP and 232,308 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.13 to $55.12, inclusive.
- Consists of 1,245,715 shares held by VHCP and 227,886 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.13 to $56.12, inclusive.
- Consists of 1,235,907 shares held by VHCP and 226,092 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.13 to $56.82, inclusive.
- Consists of 1,225,762 shares held by VHCP and 224,237 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.35 to $52.34, inclusive.
- Consists of 1,159,340 shares held by VHCP and 212,090 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.35 to $53.34, inclusive.
- Consists of 1,028,730 shares held by VHCP and 188,205 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.35 to $54.00, inclusive.
- Consists of 986,233 shares held by VHCP and 180,433 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.